3Van der Linde D, Konings E E, Slager M A, et al. Birth preva- lence of congenital heart disease worldwide: A systematic review and meta-analysis [J]. Journal of the American College of Cardi- ology, 2011,58(21): 2241-2247.
4Czeizel A E, Rockenbauer M, Sorensen H T, et al. The terato- genic risk of trimethoprim- sulfonamides: A population based case-control study [J]. Reproductive Toxicology, 2001, 15(6): 637-646.
5Bukowiecki N, Lienemann P, Hill M, et al. Real-world emission factors for antimony and other brake wear related trace elements: Size-segregated values for light and heavy duty vehicles [J]. Envi- ronmental Science & Technology, 2009,43(21): 8072-8078.
6Filella M, Belzile N, Chen Y W. Human exposure to antimony. II. Contents in some human tissues often used in biomonitoring (hair, nails, teeth) [J]. Critical Reviews in Environmental Sci- ence and Technology, 2012, 42(10): 1058-1115.
7Callahan M A. Water-related environmental fate of 129 priority pollutants [M]. US: Office of Water Planning and Standards, Office of Water and Waste Management, Environmental Protec- tion Agency, 1979.
8Kuroda K, Endo G, Okamoto A, et al. Genotoxicity of berylli- um, gallium and antimony in short-term assays [J]. Mutation Research Letters, 1991,264(4): 163-170.
9Schaumltffel N, Gebel T. Heterogeneity of the DNA damage pro- voked by antimony and arsenic[J]. Mutagenesis, 1998, 13(3): 281-286.
10Wey H E, Richards D, Tirmenstein M A, et al. The role of intra- cellular calcium in antimony-induced toxicity in cultured cardi- ac myocytes [J]. Toxicology and Applied Pharmacology, 1997, 145(1):202-210.
